日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An Exosome-Based Liquid Biopsy Predicts Depth of Response and Survival Outcomes to Cetuximab and Panitumumab in Metastatic Colorectal Cancer: The EXONERATE Study

基于外泌体的液体活检可预测转移性结直肠癌患者对西妥昔单抗和帕尼单抗治疗的反应深度和生存结果:EXONERATE 研究

Xu, Caiming; Mannucci, Alessandro; Esposito, Francis; Oliveres, Helena; Alonso-Orduña, Vicente; Yubero, Alfonso; Fernández-Martos, Carlos; Salud, Antonieta; Gallego, Javier; Martín-Richard, Marta; Fernández-Plana, Julen; Guillot, Mónica; Aparicio, Jorge; Fakih, Marwan; Kopetz, Scott; Feliu, Jaime; Maurel, Joan; Goel, Ajay

A Closer Look at Periocular Necrotizing Fasciitis: A Systematic Review of Literature

对眼周坏死性筋膜炎的深入研究:文献系统综述

Oliver-Gutierrez, David; Ros-Sanchez, Elena; Segura-Duch, Gloria; Alonso, Tirso; Arcediano, Miguel Ángel; Herranz-Cabarcos, Alejandra; Matas, Jessica; Castro Seco, Roberto; van der Veen, R L P; Boixadera, Anna; García-Arumí, José; Oliveres, Joan

Patient satisfaction after outpatient hysteroscopy: a retrospective descriptive study

门诊宫腔镜检查后患者满意度:一项回顾性描述性研究

Sanchez Carbonell, Claudia; Rovira Pampalona, Jennifer; Oliveres Amor, Carla; Caballol Arteaga, Alexandra; Degollada, Maria; Brescó Torras, Pere

A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study

一项针对已接受治疗的错配修复功能正常 (MSS) 转移性结直肠癌患者的 I-II 期多中心试验,试验中使用 Avelumab 加自体树突状细胞疫苗;GEMCAD 1602 研究

Marta Español-Rego, Carlos Fernández-Martos, Elena Elez, Carles Foguet, Leire Pedrosa, Nuria Rodríguez, Ana Ruiz-Casado, Estela Pineda, Joan Cid, Raquel Cabezón, Helena Oliveres, Miquel Lozano, Angels Ginés, Angeles García-Criado, Juan Ramon Ayuso, Mario Pagés, Miriam Cuatrecasas, Ferràn Torres, Tim

Health-related quality of life in women aged 20-64 years with urinary incontinence

20-64岁尿失禁女性的健康相关生活质量

Ramírez, Julieta Aránguiz; Tirado, Pedro Olivares; Samur, Carlos Sandaña; Gamboa, Carolina Vidal; Oliveres, Xavier Castells

1630P Effectivity and safety of anti-SARS-CoV2 vaccination in patients with lung cancer: The VAC-CaP observational study (GECP 21/01)

1630P 抗SARS-CoV-2疫苗在肺癌患者中的有效性和安全性:VAC-CaP观察性研究(GECP 21/01)

Hersby, D S; Do, T H; Gang, A O; Nielsen, T H; Ghiglione, L; Auclin, E; Aguilar-Company, J; Epaillard, N; Casadevall Aguilar, D; Masfarré, L; Rodriguez Castells, M; Tagliamento, M; Pilotto, S; Lopez Castro, R; Mielgo Rubio, X; Urbano Centella, C; Laguna, JC; García-Illescas, D; Bluthgen, MV; Gorría Puga, T; Minatta, JN; Cruz, CA; Prat, A; Mezquita, L; Soosaipillai, GB; Sureda, A; Maluquer Artigal, C; Benafif, S; Chopra, N; Harbeck, N; Wuerstlein, R; Mesia Nin, R; Felip, E; Ottaviani, D; Galazi, M; Lee, AJX; Salazar, R; Sharkey, R; Reyes, R; Evans, J; Carmona Garcia, MC; Tabernero, J; Prat, A; Pinato, DJ; Stewart, CA; Gay, C; Ramkumar, K; Cargill, KR; Cardnell, R; Nilsson, M; Heeke, S; Park, EM; Kundu, S; Diao, L; Wang, Q; Shen, L; Xi, Y; Della Corte, CM; Kundu, K; Gibbons, DL; Wang, J; Heymach, JV; Byers, LA; Agbarya, A; Addeo, A; Charpidou, A; Araújo, A; Cuppens, K; Brustugun, OT; Rajer, M; Jakopovic, M; Marinca, MV; Pluzanski, A; Marta, GDH; Auclin, E; Saoudi Gonzalez, N; Casadevall Aguilar, D; Rodriguez Castells, M; Epaillard, N; Tagliamento, M; Pilotto, S; López-Castro, R; Mielgo Rubio, X; Urbano Centella, C; Pineda, E; Laia, FM; Mirallas, O; Bluthgen, MV; Masfarré, L; Minatta, JN; Cruz, CA; Prat, A; Mezquita, L; Seguí, E; Auclin, E; Casadevall, D; Aguilar-Company, J; Rodriguez, M; Epaillard, N; Tagliamento, M; Pilotto, S; López-Castro, R; Mielgo, X; Urbano, C; Rodríguez, A; García-Illescas, D; Bluthgen, MV; Masfarré, L; Oliveres, H; Minatta, JN; Marco-Hernández, J; Prat, A; Mezquita, L; García-Illescas, D; Saoudi Gonzalez, N; Mirallas, O; Aguilar-Company, J; Ruiz-Camps, I; Garcia-Alvarez, A; Lostes Bardaji, MJ; Valdivia, A; Marmolejo Castaneda, DH; Rezqallah Aron, MA; López Valbuena, DE; Felip, E; Carles, J; Tabernero, J; Saura, C; Molinier, O; Falchero, L; Monnet, I; Decroisette, C; Neidhart, A-C; Redureau, E; Chiappa, A-M; Bigot, F; Bedossa, A; Amrane, K; Jeandeau, S; Dujon, C; Bugnet, A-S; Bonnefoy, P; Alizon, C; Meyer, N; Couraud, S; Cortot, A; Letierce, A; Debieuvre, D; Nadal, E; Moran Bueno, MT; Rodriguez Abreu, D; Vidales Sepulveda, Z; Sala Gonzalez, MA; Antonanzas Basa, M; Garcia Gonzalez, JJ; Diz Tain, P; Martinez Kareaga, M; Lopez Vivanco, G; Baena Espinar, J; Campos Balea, B; Cumplido Buron, D; Cerezo Gonzalez, S; Diaz, A; Guirado, M; Mielgo Rubio, X; Juan Vidal, OJ; Saigi Morgui, M; Provencio Pulla, M

A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomes

一种新的基因特征揭示了三种不同的免疫代谢重组模式,这些模式在不同肿瘤类型中是保守的,并且与结果相关

Leire Pedrosa, Carles Foguet, Helena Oliveres, Iván Archilla, Marta García de Herreros, Adela Rodríguez, Antonio Postigo, Daniel Benítez-Ribas, Jordi Camps, Miriam Cuatrecasas, Antoni Castells, Aleix Prat, Timothy M Thomson, Joan Maurel, Marta Cascante

Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53-Mutated Metastatic Colorectal Cancer

SMAD4和FBXW7的突变状态影响TP53突变型转移性结直肠癌的临床结局

Lahoz, Sara; Rodríguez, Adela; Fernández, Laia; Gorría, Teresa; Moreno, Reinaldo; Esposito, Francis; Oliveres, Helena; Albiol, Santiago; Saurí, Tamara; Pesantez, David; Riu, Gisela; Cuatrecasas, Miriam; Jares, Pedro; Pedrosa, Leire; Pineda, Estela; Postigo, Antonio; Castells, Antoni; Prat, Aleix; Maurel, Joan; Camps, Jordi

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)

一项随机 II 期试验比较了 FOLFIRI-帕尼单抗与单独使用 FOLFIRI 治疗 RAS 野生型循环肿瘤 DNA 转移性结直肠癌患者(一线 FOLFOX-帕尼单抗治疗后进展)的效果:BEYOND 研究 (GEMCAD 17-01)

Aparicio, Jorge; Virgili Manrique, Anna C; Capdevila, Jaume; Muñoz Boza, Félix; Galván, Patricia; Richart, Paula; Oliveres, Helena; Páez, David; Hernando, Jorge; Serrano, Sara; Vera, Ruth; Hernandez-Yagüe, Xavier; Gallego, Rafael Álvarez; Riesco-Martinez, M Carmen; García de Albeniz, Xavier; Maurel, Joan

Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?

随机临床试验的质量和 ESMO 临床获益程度量表是否是同一枚硬币的两面,用于对药物批准建议进行分级?

Rodriguez, Adela; Esposito, Francis; Oliveres, Helena; Torres, Ferran; Maurel, Joan